Most Promising Cancer Treatment Advances of 2011

December 29, 2011

New treatment therapies and promising results from a variety of clinical trials over this year are giving new hope to people affected by cancer. Showcased at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO), held this past June in Chicago, these advances and breakthroughs in cancer treatments were especially encouraging for people with melanoma, breast cancer, lung cancer and numerous other diagnoses which have been difficult to treat.

CancerCare has compiled these most promising findings in its new booklet, Your Guide to the Latest Cancer Research and Treatments: Highlights from ASCO 2011, available online now. You can also order your free copies from our publications page.

Share

Support Groups for Men with Cancer

September 30, 2011

A cancer diagnosis can have a profound impact on a man’s sense of identity and purpose in life, especially if he cannot work during or after his treatment  or has to reduce the hours he works, notes a new article on the Cancer and Careers website (www.cancerandcareers.org).

CancerCare Director of Clinical Services William Goeren, LCSW-R observes that many men who are diagnosed with cancer have a difficult time coping with their reduced income and its emotional and financial impact on their family.  Men with cancer are at a higher risk of being diagnosed with depression than women with cancer and the article offers tips for coping with these feelings.

Read the article.

CancerCare offers specialized services for men who are coping with cancer, including online, telephone, or face-to-face support groups (available in our New York City office).

Register to participate in a men’s cancers support group.

Share

New Treatment for Advanced Prostate Cancer

May 3, 2011

This past Friday’s Connect Education Workshop, What’s New in Metastatic Prostate Cancer, coincided with the FDA’s approval of a new treatment for advanced prostate cancer.

Zytiga, a pill that decreases the production of a hormone that stimulates cancer cells to grow, prolonged the lives of men with late-stage prostate cancer who had received prior treatments and had few available therapeutic options. Listen to the workshop.

Learn more about Zytiga.

CancerCare offers free support services for people affected by prostate cancer, including an online support group for men affected by cancer. We are also recruiting participants for a face-to-face men’s cancers support group. Register and learn more about CancerCare’s free support groups.

Men who are affected by prostate cancer may also be eligible to receive up to $5,000 per year in co-payment assistance through the CancerCare Co-Payment Assistance Foundation. Learn more.

Share

Have a Question About Men’s Cancers? Ask CancerCare

April 8, 2011

Men’s cancers are the focus of April’s “Ask CancerCare,” a column that provides answers to your questions from our experts.

CancerCare professional oncology social worker William Goeren, LCSW-R, is this month’s expert. Goeren recently responded to a question about treatment side effects and emotional issues experienced by a man affected by breast cancer —read his response.

Submit your own question for the chance to have it answered in this column. All posts are completely anonymous.

Share

Men Affected by Cancer Connect Through Support Group

September 21, 2010

This September, CancerCare launched a new, professionally led support group in New York City for men, focusing on “Sexual Health After Cancer.” The group, led by CancerCare Men’s Cancers Program Director Bill Goeren, LCSW-R, ACSW, brought together 20 participants, who shared their concerns and insights about intimacy and sexual health during and after cancer treatment.

While the majority of participants were prostate cancer survivors, the group also included men diagnosed with myeloma, head and neck cancer, colon cancer, and throat cancer.

Though their experiences were unique, a common thread binding the men in the group was their anxiety and uncertainty about the impact of their cancer and treatment on their sexuality, noted Goeren. 

“Men can often be hesitant to discuss their emotions and feelings,” he said.  “Once the ice was broken, though, the group really opened up and asked the questions they wanted to ask,” such as whether they would be able to continue or resume physical intimacy with their partner. The men also shared how they were affected emotionally by the temporary or permanent loss of sexual function due to their illness and treatment, and how that loss redefined their intimate relationships.

CancerCare will offer its professionally moderated men’s cancers support group throughout the fall and winter. Future discussion topics will include exercise and nutrition, work and careers, and how to talk to your children about cancer.

For more information about CancerCare’s programs for men affected by cancer, contact Goeren at 212-712-6141 or email wgoeren@cancercare.org.

Share

Free Support Available for Ovarian Cancer and Prostate Cancer Patients

September 2, 2010

September is both Ovarian Cancer Awareness Month and National Prostate Cancer Awareness Month.

CancerCare partnered with L’Oreal Paris and Ovarian Cancer Research Fund (OCRF) to create a free telephone counseling and referral service for women diagnosed with ovarian cancer. 

Launched one year ago, The L’Oreal Paris OCRF Hopeline has proven to be a great source of support for many women facing an ovarian cancer diagnosis. The Hopeline is staffed by professional oncology social workers and operates Monday through Friday, 9 a.m. to 5 p.m. Eastern Time.

Call the L’Oréal Paris OCRF Hope Line at 877-OV-HOPE-1 (877-684-6731).

CancerCare responded to the needs of men facing prostate cancer by publishing two new fact sheets: Caring for Your Bones When You Have Prostate Cancer and Prostate Cancer: What You Should Know About Screening and Diagnosis. 

For more resources on these cancers, including additional publications, support groups and archived connect education workshops, visit the diagnoses pages on our website.

Share